SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

FERRARESE, Mattia
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.440
EU - Europa 2.903
AS - Asia 2.155
SA - Sud America 304
Continente sconosciuto - Info sul continente non disponibili 150
AF - Africa 63
OC - Oceania 3
Totale 9.018
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.331
FI - Finlandia 1.922
SG - Singapore 791
CN - Cina 542
IT - Italia 279
BR - Brasile 235
VN - Vietnam 235
DE - Germania 159
HK - Hong Kong 158
GB - Regno Unito 93
PL - Polonia 75
JP - Giappone 71
ID - Indonesia 68
FR - Francia 67
TR - Turchia 67
UA - Ucraina 65
CA - Canada 54
RU - Federazione Russa 47
SE - Svezia 47
BD - Bangladesh 46
IN - India 43
MX - Messico 35
AR - Argentina 27
NO - Norvegia 22
PK - Pakistan 22
IQ - Iraq 19
ES - Italia 18
NL - Olanda 18
CZ - Repubblica Ceca 17
ZA - Sudafrica 17
BE - Belgio 15
EC - Ecuador 12
IR - Iran 12
KE - Kenya 11
VE - Venezuela 11
AT - Austria 10
MY - Malesia 10
MA - Marocco 9
SA - Arabia Saudita 9
IE - Irlanda 8
LT - Lituania 8
UZ - Uzbekistan 8
CL - Cile 7
CO - Colombia 7
KR - Corea 7
DK - Danimarca 6
IL - Israele 6
JM - Giamaica 6
PT - Portogallo 6
AZ - Azerbaigian 5
AE - Emirati Arabi Uniti 4
AL - Albania 4
CR - Costa Rica 4
DZ - Algeria 4
EG - Egitto 4
ET - Etiopia 4
GE - Georgia 4
PH - Filippine 4
TH - Thailandia 4
TT - Trinidad e Tobago 4
AU - Australia 3
CH - Svizzera 3
GT - Guatemala 3
JO - Giordania 3
NP - Nepal 3
PY - Paraguay 3
TN - Tunisia 3
BH - Bahrain 2
HR - Croazia 2
KZ - Kazakistan 2
LK - Sri Lanka 2
NG - Nigeria 2
RO - Romania 2
SN - Senegal 2
SV - El Salvador 2
TW - Taiwan 2
BA - Bosnia-Erzegovina 1
BF - Burkina Faso 1
BG - Bulgaria 1
BO - Bolivia 1
BW - Botswana 1
CG - Congo 1
EU - Europa 1
GA - Gabon 1
GR - Grecia 1
HN - Honduras 1
HU - Ungheria 1
KG - Kirghizistan 1
LB - Libano 1
LU - Lussemburgo 1
LV - Lettonia 1
MK - Macedonia 1
MN - Mongolia 1
MT - Malta 1
MU - Mauritius 1
OM - Oman 1
PS - Palestinian Territory 1
RE - Reunion 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 8.866
Salva come PNG Salva come JPEG
Città #
Helsinki 1.907
Singapore 515
Ashburn 395
San Jose 275
Chandler 212
Santa Clara 199
Fairfield 196
Beijing 178
Hong Kong 150
Council Bluffs 146
Woodbridge 131
Dallas 121
Ferrara 113
New York 100
Seattle 91
Houston 82
Ho Chi Minh City 80
Los Angeles 72
Wilmington 71
Warsaw 69
Cambridge 67
Ann Arbor 64
Tokyo 61
Hanoi 57
Jakarta 57
Munich 57
Izmir 47
Princeton 44
Shanghai 44
Jacksonville 43
Nanjing 37
São Paulo 35
Dearborn 34
Lauterbourg 33
Milan 33
Bremen 22
Chicago 22
Denver 21
Orem 21
Toronto 20
Phoenix 19
Brooklyn 16
London 16
Montreal 16
Oslo 16
Boardman 15
Mexico City 15
Moscow 15
Nanchang 15
Atlanta 14
Poplar 14
Brno 13
Guangzhou 13
Falkenstein 12
Lahore 12
Redwood City 12
Rio de Janeiro 12
San Diego 12
The Dalles 12
Da Nang 11
Rome 11
Bologna 10
Brussels 10
Dong Ket 10
Manchester 10
San Francisco 10
Shenyang 10
Hebei 9
Johannesburg 9
Tianjin 9
Baghdad 8
Brasília 8
Frankfurt am Main 8
Haiphong 8
Jiaxing 8
Nairobi 8
Boston 7
Buffalo 7
Chennai 7
Kyiv 7
Mumbai 7
Stockholm 7
Tashkent 7
Turku 7
Washington 7
Zhengzhou 7
Amsterdam 6
Copenhagen 6
Fairford 6
Indore 6
Kuala Lumpur 6
Kunming 6
Nuremberg 6
Piemonte 6
Quito 6
Santiago 6
Andover 5
Belo Horizonte 5
Curitiba 5
Ferrara di Monte Baldo 5
Totale 6.498
Salva come PNG Salva come JPEG
Nome #
A strategy with chaperone-like compounds to restore expression of factor IX variants affected by frequent missense mutations causing hemophilia B 2.061
Akt-mediated phosphorylation of MICU1 regulates mitochondrial Ca 2+ levels and tumor growth 318
Differential functional readthrough over homozygous nonsense mutations contributes to the bleeding phenotype in coagulation factor VII deficiency 314
Responsiveness of hemophilia B- causing non sense mutations to ribosome readthrough-inducing drugs strictly depends on the nucleotide and prrotein context 255
Transposon-mediated Generation of Cellular and Mouse Models of Splicing Mutations to Assess the Efficacy of snRNA-based Therapeutics 249
An Altered Splicing Registry Explains the Differential ExSpeU1-Mediated Rescue of Splicing Mutations Causing Haemophilia A 242
An engineered human albumin enhances half-life and transmucosal delivery when fused to protein-based biologics 226
The chaperone-like sodium phenylbutyrate improves factor IX intracellular trafficking and activity impaired by the frequent p.R294Q mutation 218
Missense changes in the catalytic domain of coagulation factor X account for minimal function preventing a perinatal lethal condition 217
The carboxyl-terminal region of human coagulation factor X as a novel naturally-occuring linker for fusion strategies 215
Specific factor IX mRNA and protein features favor drug-induced readthrough over recurrent nonsense mutations 209
A Compensatory U1snRNA Partially Rescues FAH Splicing and Protein Expression in a Splicing-Defective Mouse Model of Tyrosinemia Type I 190
Secretion of wild-type factor IX upon readthrough over F9 pre-peptide nonsense mutations causing hemophilia B 188
An exon-specific small nuclear u1 rna (Exspeu1) improves hepatic otc expression in a splicing-defective spf /ash mouse model of ornithine transcarbamylase deficiency 186
Protein engineering and pharmacological approaches to develop novel treatment strategies for coagulation disorders 184
Secretion of wild-type factor IX upon readthrough over F9 pre-peptide nonsense mutations causing hemophilia B 183
A next-generation rFVIIa fusion protein with enhanced half-life as a novel by-passing tool in hemophilia 180
The chaperone-like compound sodium phenylbutyrate improves intracellular trafficking, secretion and coagulant activity of factor IX impaired by the frequent p.R294Q mutation 180
Mutation-specific contributions to trace factor X levels account for a life-threating phenotype in a compound heterozygous factor X deficient patient 176
Fusion of engineered albumin with factor IX Padua extends half-life and improves coagulant activity 174
Rational engineering of a novel factor IX albumin fusion protein results in enhanced coagulant activity and pharmacokinetic profile 173
Design of a novel factor IX albumin fusion protein with enhanced coagulant activity and pharmacokinetic profile 167
Exploring chaperone-like compounds as innovative therapeutic correction approach for factor IX missense mutations causing type I Haemophilia B 167
Comparative Analysis Of Residual Factor VIII Expression from Recurrent F8 Nonsense Mutations Indicates that Localization in the B- domain Favours Readthrough- mediated Protein Output 165
An optimized in vitro expression platform identifies Haemophilia B nonsense mutations, and thus patients, eligible for therapeutic drug-induced readthrough 165
The carboxyl-terminal region of human coagulation factor X as a natural linker for fusion strategies 163
Detection of Residual Factor VIII Levels Reveals the Occurrence of Readthrough Over the Majority of F8 Nonsense Mutations 162
An advanced method for the small-scale production of high-quality minicircle DNA 160
Translational readthrough of GLA nonsense mutations suggests dominant-negative effects exerted by the interaction of wild-type and missense variants 159
Design of a novel factor IX variant with enhanced procoagulant activity and half-life 158
Readthrough-mediated functional suppression of homozygous nonsense mutations accounts for variable bleeding phenotypes in factor VII deficiency 152
Exploring chaperone-like compounds as innovative therapeutic strategy for Hemophilia B 149
Identification of novel mechanisms underlying functional response to drug-induced readthrough of haemophilia B nonsense mutations 144
Spontaneous readthrough over recurrent F8 nonsense mutations is associated with residual factor VIII levels: implications for inhibitor risk? 135
Next generation factor VIIa with enhanced half-life 128
Recombinant Expression of F9 Nonsense Mutations and Fix Pharmacokinetics in Hemophilia B 107
Noncanonical type 2B von Willebrand disease associated with mutations in the VWF D'D3 and D4 domains 107
Suppression of “leaky” nonsense mutations by ribosome readthrough accounts for residual factor IX levels in Haemophilia B patients 100
Translational readthrough at F8 nonsense variants in the factor VIII B domain contributes to residual expression and lowers inhibitor association 99
null 93
Totale 9.018
Salva come PNG Salva come JPEG
Categoria #
all - tutte 35.958
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 35.958
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022264 0 0 8 4 21 22 5 12 17 31 21 123
2022/2023436 48 61 12 62 62 50 30 31 42 5 18 15
2023/2024285 10 23 16 4 17 61 15 30 6 9 12 82
2024/20251.124 36 20 97 29 130 167 20 23 178 103 181 140
2025/20265.031 299 181 229 415 460 222 374 183 2.138 329 126 75
2026/2027327 67 149 111 0 0 0 0 0 0 0 0 0
Totale 9.018